和晶科技(300279) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥402,775,066.27, a decrease of 19.28% compared to ¥499,000,964.08 in the same period last year[5] - Net profit attributable to shareholders was ¥9,567,409.62, a significant increase of 125.32% from a loss of ¥37,791,347.66 in the previous year[5] - Basic earnings per share improved to ¥0.0199 from a loss of ¥0.0861, marking a 123.11% increase[5] - The company's net loss for Q1 2023 was significantly reduced to CNY 1,607,172.37 from a loss of CNY 49,570,818.27 in the previous year[28] - Operating profit for the quarter was ¥13,304,453.58, compared to an operating loss of ¥34,955,279.45 in Q1 2022, indicating a recovery in operational performance[29] - The total comprehensive income for the quarter was ¥9,457,558.33, compared to a comprehensive loss of ¥37,838,127.03 in Q1 2022, showing a significant recovery[29] Cash Flow and Financial Position - The net cash flow from operating activities decreased by 45.08% to ¥5,350,730.87 from ¥9,742,819.13 in the previous year[13] - Cash and cash equivalents decreased to CNY 371,771,964.66 from CNY 457,995,767.43 at the beginning of the year, a decline of 18.8%[26] - The company reported a cash and cash equivalents balance of ¥230,312,118.57 at the end of Q1 2023, down from ¥257,569,352.14 at the beginning of the quarter, representing a decrease of about 10.5%[32] - The company incurred a total of ¥148,829,301.25 in cash outflows from financing activities, slightly down from ¥153,812,606.37 in the previous year, indicating a reduction of about 3.2%[32] - The net cash flow from investing activities was negative at -¥8,572,323.38, consistent with the previous year's outflow of -¥9,525,450.86, showing a decrease of about 10%[31] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,338,491,731.29, down 4.50% from ¥2,448,594,122.83 at the end of the previous year[5] - Current liabilities decreased to CNY 1,424,657,406.90 from CNY 1,543,339,862.99, a decrease of 7.7%[26] - Accounts receivable decreased to CNY 496,146,288.89 from CNY 548,457,141.99, representing a reduction of 9.5%[26] - Inventory increased to CNY 525,916,751.01 from CNY 507,048,443.22, an increase of 3.5%[26] - The company's equity attributable to shareholders increased to CNY 840,742,772.42 from CNY 831,175,362.80, an increase of 1.4%[27] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 21,624, with the top shareholder holding 17.35% of the shares[14] - The company has a total of 128,226,287 shares controlled by its major shareholder, accounting for 26.69% of the total share capital[17] - The company has renewed the voting rights entrustment agreement, allowing the major shareholder to exercise voting rights for 44,856,287 shares for another three years[17] - The company’s major shareholder, Jingzhou Huihe, has a total of 83,370,000 shares, representing a significant portion of the voting rights[17] - The company has not disclosed any other shareholder relationships or agreements beyond the major shareholder's voting rights[17] Impairment and Losses - The company experienced a 148.15% increase in credit impairment losses, amounting to ¥4,132,454.71, mainly due to a reduction in receivables[11] - The company reported an investment loss of 9.8469 million RMB from its equity investment in Beijing Huanyu Wanwei Technology Co., Ltd. for the year 2022[21] - The company has fully provided for impairment on its long-term equity investment in Huanyu Wanwei, amounting to 167.8074 million RMB[21] - The company has been notified of the bankruptcy liquidation application for its associate company, Huanyu Wanwei[20] Financial Reporting - The company's financial reports are prepared in accordance with the relevant accounting standards and regulations[24] - Total operating revenue for Q1 2023 was CNY 402,775,066.27, a decrease of 19.3% compared to CNY 499,000,964.08 in the same period last year[28] - Total operating costs for Q1 2023 were CNY 393,922,665.29, down 19.3% from CNY 487,867,711.63 in Q1 2022[28] - Research and development expenses for Q1 2023 were CNY 19,110,151.07, up from CNY 17,122,423.17, an increase of 11.6%[28]